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Koi herpesvirus (KHV) caused signiﬁcant morbidity and mortality in koi and common carp (Cyprinus
carpio). Glycoprotein has been used for vaccine development as sub unit vaccine against many viruses.
KHV ORF25 is one of koi herpesvirus genes which encode a glycoprotein. The objectives of this research
are to clone gene KHV ORF25 and express its protein. The common carp showing necrosis and white
patches of gill which was collected from Magelang was used in this research. Primers were designed to
amplify partial ORF25 based on KHV J strain. KHV ORF25 was successfully ampliﬁed and cloned in
pET32a. Sequence analysis showed that this KHV ORF25 has 99% homology with the sequences of KHV
genotype KHV-J, KHV-I, and KHV-U. This ORF was predicted has 3, 23, and 8 B-cell epitopes based on
Emini scale, Karplus and Schulz scale, and ElliPro respectively. The KHV ORF25 recombinant protein has
been successfully produced in Escherichia coli as an insoluble protein with approximately 45 kDa in size.
The high protein production was achieved when the protein induction was done at bacterial density at
OD600 as 1.0 with 1-mM isopropyl b-D-1-thiogalactopyranoside (IPTG) and incubated at 37

C for
18 hours. The protein predicted has immunogenicity and the potency as a vaccine is needed to be
evaluated.
Copyright © 2016 Institut Pertanian Bogor. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Diseases are major aquaculture problems that impact the
quantity and quality of aquaculture products and signiﬁcantly
decrease the economy of aquaculture industry. Koi herpesvirus
(KHV) also known as, cyprinid herpesvirus 3, koi herpes-like virus,
and carp interstitial nephritis gill necrosis virus caused signiﬁcant
morbidity and mortality both in common carp and koi carp
(Hedrick et al. 2000; Michel et al. 2010; Ilouze et al. 2011). The ﬁrst
outbreak of KHV was reported in 1998 and conﬁrmed in 1999 in
Israel. Since then, other cases have been conﬁrmed in United States,
Europe, and Asia (Hedrick et al. 2000). In Indonesia, KHV infection
was started in Blitar, East Java, in March 2002. It spread rapidly
through Java Island and caused very high mortality (80%e90%).
From Java island the KHV spread into Sumatra, Borneo and other
islands (Sunarto and Cameron 2006).
KHV is classiﬁed within the Alloherpesviridae family, consisting
of a linear, double-stranded DNA genome of about 295 kbpmurwantoko@yahoo.com
nian Bogor.
r. Production and hosting by Elspackaged within an icosahedral capsid of characteristic architec-
ture that is surrounded by a proteinaceous tegument layer and
ﬁnally by a host-derived envelope containing virus glycoproteins
(Aoki et al. 2007). Beside the linear form, Fujioka et al. (2015) also
reported the genome KHV presence in circular or concatemeric
double DNA form. This difference was suspected to be because KHV
genome may be circularized for long-term maintenance without
active viral replication. Aoki et al. (2007) reported that the com-
plete genome sequences of KHV isolates from the USA (KHV-U),
Israel (KHV-I) and Japan (KHV-J) share >99% nucleotide sequence
identity. They suggested that an ancestral KHV initially diverged
into two genetic lineages, KHV-U/I (European genotype) and KHV-J
(Asian genotype). The polymerase chain reaction (PCR) patterns
and sequence analysis based on the alleles of three domains of an
alternate KHV classiﬁcation system conﬁrmed that the genotype of
the KHV BA-08 isolate was cyprinid herpesvirus 3ethird genotype
(Kim and Kwon 2013)
Based on the observed pattern of polymorphism, Kurita et al.
(2009) reported KHV samples were roughly divided into two
groups, designated as Asian and European genotypes with each
genotype containing two and seven variants, respectively. The ho-
mogeneity of Asian KHVs suggests that invasion of KHV into these
areas occurred more recently and the virus spread rapidly when
compared to the case of European KHV. The all 10 samples fromevier B.V. This is an open access article under the CC BY-NC-ND license (http://
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Genotype with A1 and A2 variants. Subsequently, Dong et al. (2013)
conﬁrmed the emergence of the U/I genotype in adult koi suffering
mass mortality in China in 2011. Based on the TK and ORF136H
genes, the sequence analyses revealed that KHV-GZ11 is a distinct
European genotype of KHV. This virus was further studied at a
whole genome level by Li et al. (2015b).
Vaccination of ﬁsh is one way to prevent ﬁsh disease due to KHV
infection. Yuasa and Sano (2009) reported that development of
vaccine is one of the development of preventive measures against
KHV in Japan. Immunologic studies by naturally resistant and im-
munization of attenuated virus have shown a signiﬁcant elevation
of the humoral response to vaccination. Furthermore, both viral
inoculation and challenge showed very high anti-viral resistance
and lowmortality (Ronen et al. 2003). Adkison et al. (2005) showed
that survivor of KHV outbreak showed high titer antibody against
KHV and the passive immunization could protect carp from KHV
infection. Yasumoto et al. (2006) and Miyazaki et al. (2008) have
proved the efﬁcacy of oral immunization with the liposome-KHV
vaccine was efﬁcacious against KHV infection in carp.
KHV ORF25, one of membrane glycoprotein of KHV (Aoki et al.
2007), has immunogenic properties as shown by DNA vaccination
against KHV (Nuryati et al. 2010; Nuswantoro et al. 2012; Zhou et al.
2014). Beside the DNA vaccine, the recombinant proteins can be
used as ﬁsh vaccines (Lecocq-Xhonneux et al. 1994; Sommerset
et al. 2005; Lin et al. 2007; Shin et al. 2013; Kim et al. 2015; Li et
al. 2015a), In this study we cloned KHV ORF25 from Indonesian
virus, expressed the protein in Escherichia coli and explored the
potency of it as a vaccine candidate.
2. Materials and Methods
2.1. Sample
Common carp (Cyprinus carpio) showing symptoms as necrosis
and white patches of gills which was obtained from Magelang,
Central Java in June 2012 was used in this study. DNA isolation was
done from the gills using Tris-NaCl-EDTA-SDS (TNES) buffer
method (Murwantoko 2009). Conﬁrmation of KHV infection was
carried out by PCR based on thymidine kinase primers, KHV-TKf
(GGGTTACCTGTACGAG) and KHV-TKr (CACCCAGTAGATTATGC)
(Bercovier et al. 2005).
2.2. Primer design
Previous studies showed that KHV Indonesian isolates were
closely related to KHV-J from Japan (Murwantoko 2009; Sunarto
et al. 2011; Murwantoko et al. 2012), so the primer sequences
were designed based on TUMST1 KHV strain (Japan; accession
number AP008984) as a template. The GC content, self-annealing
loops, and hairpin loops were checked using Oligocalculator soft-
ware (http://www.basic.northwestern.Edu/biotools/oligocalc.
Html). Primers were designed to amplify DNA fragment which
encoded partial ORF25 protein excluding the hydrophobic amino
acids cluster. The primers were 28 bp in length with an additional
EcoRI restriction site on the forward primer and HindIII restriction
site in the reverse primer. Those primers are: KHV-ORF25-F:
AGCTGAATTCGGTTCGAGGACCAACGTC, and KHV-ORF25-R:
AGATAAGCTTCAGGTTTCCCCTGCGCCA.
2.3. DNA ampliﬁcation and purifying from gel agarose
Ampliﬁcation of DNA KHV using thymidine kinase and ORF25
primer pairs was performed using Thermalcycler Mastercycler Per-
sonal (Eppendorf, Germany) using PCR Mix Kappa (Biosystems).
The PCR reaction was conducted as follows: one cycle of 95C for 5
minutes, 30 cycles of 94C for 30 seconds, 56C for 30 seconds, 72C
for 75 seconds, followed by one cycle with 72C for 5 minutes. PCRreactions were evaluated by 1% agarose electrophoresis (Nacalai)
on Tris-acetate-ethylenediaminetetraacetic acid (TAE) (40mM Tris-
acetate pH 8.3, 1 mM ethylenediaminetetraacetic acid (EDTA)) us-
ing Mupid Advance horizontal electrophoresis (Advance, Japan).
The gel was stainedwith ethidium bromide and observed under UV
transilluminator (Extra Gene, Taiwan)
The PCR products of ORF25 were puriﬁed using phenol-
chloroform and followed by digestion with EcoR1 and HindIII
(Toyobo) at 37C for 2 hours, then were agarose electrophoreted.
The desired band DNA was excised and DNA was recovered from
agarose using Ron's Gel Extraction kit (BIORON). Puriﬁed PCR
fragment was ligated into pET-32a(þ) (Novagen) using T4 DNA
ligase (Toyobo) at 16C overnight. Ligation mixture was trans-
formed into Escherichia coli DH5a using heat shock on 42C for 90
seconds followed by incubation on ice (Sambrook and Russell
2001). The bacteria were cultured on LB agar containing 50 mg/
mL ampicillin overnight. The growth colonies were cultured in LB
broth containing ampicillin and cultured at 37C overnight. The
plasmids were isolated from the bacteria using mini preparation of
alkali lysis methods (Sambrook and Russel 2001). The presence of
recombinant plasmid was checked by digestion of plasmid using
EcoRI and HindIII enzymes (Toyobo).
2.4. Sequencing and data analysis
The recombinant plasmids were sequenced using S-Tag and T7-
terminator primers by company service (Macrogen). DNA se-
quences from those two primers were overlapped to determine
complete sequences. DNA sequences were analyzed using basic
local alignment search tool (BLAST) to looking for the homology
with the data on GenBank. The T-cell epitopes were predicted by
GENETYX based on the pattern IAd (Sette et al. 1989) and patterns
of Rothbard/Taylor (Rothbard and Taylor 1988). The prediction of B-
cell epitopewas conducted using the B Cell epitope Prediction Tools
from immune epitope database (IEDB) (http://tools.iedb.org/main/
html/bcell_tools.html) based on Emini surface accessibility scale
(Emini et al. 1985), Karplus and Schulz ﬂexibility scale (Karplus and
Schulz 1985) and ElliPro (Ponomarenko et al. 2008).
2.5. Protein production
The recombinant plasmid of pET32-KHV-ORF25 was trans-
formed into E. coli BL21 DE3 using heat shock method described
previously. Bacteria were inoculated into 100 mL of LB broth con-
taining ampicillin (50 mg/mL), then incubated with shaker at 37C
overnight. The bacterial culture was inoculated into 1000 mL LB
broth then the protein productionwas induced by adding isopropyl
b-D-1-thiogalactopyranoside (IPTG) into medium. Bacterial cells
were harvested by centrifugation at the speed of 3500 rpm for 15
minutes on Refrigerated Centrifuge 5810R (Eppendorf). Bacterial
pellet was collected and resuspended in 10% of the mediumvolume
of phosphate-buffered saline. Bacterial cells were disrupted by
sonication using Ultrasonic Generator US-300T (Nissei, Japan).
The solubility of protein was checked by centrifugation of soni-
cated bacterial suspension at 10,000 g for 3 minutes to separate
soluble and insoluble fractions. The optimization of protein pro-
ductionwas performed by combination of different bacterial density,
concentration of IPTG and length of induction. Those treatments
were induction at optical densities (OD 600) 0.6, 0.8, and 1; induc-
tion at IPTG concentrations 0.6, 0.8 and 1 mM; and length of in-
duction 3, 6, and 18 hours. The proteinwas analyzed using 10% SDS-
PAGE (Sambrook and Russel 2001) using PAGE run vertical electro-
phoresis AE-6530 (Atto, Japan) stained by Coomassie brilliant blue.
2.6. Protein puriﬁcation
Protein puriﬁcation from sonicated bacterial suspension was
done using Ni-NTA agarose (Qiagen) in accordance with the
Figure 2. Agarose electrophoresis of isolated plasmid at native condition (A) and at
digested with EcoRI and HindIII enzymes (B). (A) M: 1 KB DNA ladder, lane 1: re-
combinant plasmid, lane 2: empty plasmid. (B) Lane 1: empty plasmid, lane 2: re-
combinant plasmid, lane 3: KHVORF25 amplicon.
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washing buffer (100 mM NaH2PO4, 10 mM TrisHCl, 8 M urea) pH 8,
6.3, 5.9 and elution buffer (100 mM NaH2PO4, 10 mM TrisHCl, 8M
urea) pH 4.5. The protein was analyzed using SDS PAGE 12%.
3. Results
3.1. KHV ORF25 ampliﬁcation
The common carp sample from Magelang was conﬁrmed to be
infected by KHV. PCR analysis with KHV-TKf and KHV-TKr primers
(Bercovier et al. 2005) using DNA from gill tissue as template pro-
duced single band at approximately 400 bp (Figure 1A lane 1). From
that DNA sample, the membrane protein ORF25 was ampliﬁed
using KHV-ORF25-F/KHV-ORF25-R primers. The single band in
approximately 1000 bp size was produced at expected size
(Figure 1B lane 1). The PCR product was digested using EcoRI and
HindIII (Figure 1B lane 2) and used for cloning.
3.2. Cloning
Transformation of ligation mixtures of pET32 and DNA insert
into E. coli DH5a produced four colonies in LB agar containing
ampicillin. Evaluation of the presence of recombinant by agarose
electrophoresis showed that a plasmid has higher molecular
weight (Figure 2A lane 1) compared to the other plasmids
(Figure 2A lane 2). Plasmid digestion by EcoRI andHindIII restriction
enzymes reconﬁrmed that the plasmid was a recombinant plasmid
as a 1000 bp band appeared (Figure 2B lane 1), whereas for the
empty plasmid, the band did not appear (Figure 2B lane 1). The size
of the inserted DNAwas the samewith the PCR product using KHV-
ORF25-F/-KHV-ORF25-R primers (Figure 2B lane 3).
3.3. Sequencing and data analysis
The recombinant plasmid was sequenced using S-Tag and T7-
terminator primers. The sequences from those primers were
overlapped to determine sequence of cloned KHV ORF25 gene. The
size of full length ORF25 are 1833 nt on KHV-TUMST1 strain and
1805 nt on KHV-U and KHV-I strains. Sequencing results showed
that this KHV ORF25 was composed only of 1012 nt, it means that
this KHV ORF25 is only partial gene (Figure 3). This sequence has
been submitted to GenBank with accession no KX538957. BLASTFigure 1. Agarose gel electrophoresis of KHV PCR products of conﬁrmation of presence
of KHV with Bercovier primer (A) M. 100 bp DNA ladder. 1. DNA sample as template. 2.
Negative control. Agarose gel electrophoresis of KHV PCR products of ORF25 (B) M: l/
HindIII DNA marker, 1: KHV ORF25 amplicon, 2: Digested KHV ORF25 amplicon with
restriction enzymes.analysis showed that only nine data entries were showing signiﬁ-
cant high homology. The result showed 99% homology with KHV
genotype KHV-J (Japan), KHV-I (Israel), and KHV-U (USA) (Aoki
et al. 2007), strain KHV-GZ11 (China) (Li et al. 2015b), isolate
SNUKHV (South Korea), strains FL (Belgium), isolate HZ419 (China),
isolate FL (Belgium). Translation into amino acids was conducted
using GENETYX program as presented in Figure 3. The multiple
alignment of this KHV with KHV strains from GenBank showed
there is one nucleotide different at number 254 (cytosine from this
isolate instead of thymine in other KHV strains) and produced
different nucleotide at translation level as alanine instead of valine
(data not shown).
Prediction of T-cell epitope of this KHVORF25 using the GEN-
ETYX program shows nine epitopes recognized by IAd pattern and
eight epitopes recognized by Rothbard/Taylor pattern. One
epitope is recognized by both IAd and Rothbard/Taylor pattern.
The prediction of B-cell epitope of KHV ORF25 was conducted
using the B Cell epitope Prediction Tools. The analysis based on
Emini surface accessibility scale, Karplus and Schulz ﬂexibility
scale and ElliPro predicted KHV ORF25 contains 3, 23, and 8 epi-
topes, respectively. At least three epitopes were predicted from
two scales and two epitopes were recognized by all three scales
(Figure 3).3.4. Protein production
The protein production was conducted under pET32a expres-
sion system. Because KHVORF25was a partial gene, the start codon
and stop codon come from plasmid. KHV ORF25 protein was suc-
cessfully produced in E. coli BL21. It can be seen on the presence of
protein at approximately 45 kDa size as a dominant band in SDS
PAGE. The protein expression can be induced by addition of IPTG at
bacterial density at OD 0.6, 0.8, and 1.0. The protein production
increases following the incubation hours of 3, 6 and 18 hours. From
those conditions, we can see that induction at bacterial density at
OD 1.0 and induction time of 18 hours produce highest protein
(Figure 4). IPTG induction at various concentrations of IPTG as 0.6,
0.8, and 1 mM did not show signiﬁcant differences on protein
production. All treatment showed the same protein band thickness
(Figure 5A). Solubility test showed that recombinant protein
ORF25 was expressed dominantly at insoluble condition
(Figure 5B).
Figure 3. Nucleotide and amino acid sequences of KHV ORF25. Sequences with underlines indicate sequences of primers. The amino acids which were predicted as F-cell epitope
based on IAd and Rothbard/Taylor patterns are indicated by I and R, respectively. The amino acids which were predicted as B-cell epitope based on Karplus and Schulz ﬂexibility
scale, Emini surface accessibility scale, and ElliPro are indicated by K, L and E, respectively.
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Figure 4. SDS PAGE of optimization of protein production by induction with 1 mM
IPTG at different bacterial density and induction time. Lane 1: non-induction, lane
2e4: induction at density OD 0.6 with induction time for 3 (lane 2), 6 (lane 3), 18 hours
(lane 4). Lane 5e7: induction at density OD 0.8 with induction time for 3 (lane 5), 6
(lane 6), 18 hours (lane 7), lane 8e10: induction at density OD 1.0 with induction time
for 3 (lane 8), 6 (lane 9), 18 hours (lane 10). M: protein size marker with indicated size.
Figure 5. SDS PAGE of IPTG induction and solubility. Optimization of IPTG concen-
tration for induction (A). E. coli at density OD 1.0 were induced with IPTG at 0.6 (lane
1), 0.8 (lane 2), and 1.0 mM (lane 3). M: Protein size marker with indicated size. (B) The
sonicated bacterial suspension (A, lane 3) was centrifuged at 10,000g for 3 minutes;
the supernatant collected as soluble fraction (lane 1); pellet was suspended in PBS as
insoluble fraction (lane 2).
Figure 6. Protein puriﬁcation using Ni-NTA agarose. Lane 1: denatured protein, lane
2e4: washing fractions, lane 5e6: elution fractions with pH 4.5 elution buffer, lane 7:
elution fraction with TE elution buffer. M: Protein marker with indicated size.
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Puriﬁcation using Ni-NTA agarose showed that target protein
was successfully bound to Ni-NTA beads as can be seen that only
small amount of the protein is found in ﬂow through or washing
fraction. Elution buffer with lower pH buffer could not release
protein from bead. Elution of the target protein using Tris-EDTA
buffer obtained results that most of target protein was success-
fully eluted and puriﬁed (Figure 6).4. Discussion
KHV caused signiﬁcant morbidity and mortality both in com-
mon carp and koi carp (Hedrick et al. 2000; Michel et al. 2010;
Ilouze et al. 2011). The external signs of KHV infected ﬁsh are
swollen and necrotic gill ﬁlaments, excessive mucus production or
discolored patches on the skin (Hedrick et al. 2005). The patho-
logical KHV signs in the gill rakers include increased subepithelial
inﬂammation and congestion of blood vessels in the gill arch,
accompanied by attenuation of the rakers' height. Severe patho-
logical changes were noted in the kidney as a mild peritubular in-
ﬂammatory inﬁltrate was evident at early infection and will be
followed by a heavy interstitial inﬂammatory inﬁltrate, along with
congestion of blood vessels (Ilouze et al. 2011). In this study, the
carp from Magelang showing necrosis and white patches of gills
was used. PCR using extracted DNA from those gills with Bercovier
primer pairs conﬁrmed that the ﬁsh was infected by KHV.
Analysis on KHV ORF2 with sample from Toba lake, North
Sumatra (Murwantoko 2009), on KHV ORF124 with sample from
Yogyakarta (Murwantoko et al. 2012), on marker I, marker II and
thymidine kinase with sample from various areas in Indonesia
(Sunarto et al. 2011) showed that all samples belonged to the KHV
Asian lineage. In this study KHV ORF2 from Magelang, Central Java
showed same homology with the KHV Asian and European geno-
types. This result showed that ORF25 cannot be used to differen-
tiate the lineage.
Vaccination is an important approach to control disease. Ronen
et al. (2003) have proved that KHV can be developed as an efﬁ-
cient vaccine since using of attenuated virus on viral inoculation
and challenge resulted in high levels of antibodies against the
virus and very high anti-viral resistance. This result was also
supported by Adkison et al. (2005) using an enzyme-linked
immunosorbent assay, they detected the presence of anti-
KHV antibodies in the serum of koi following either natural or
experimental exposures to KHV. In order to reduce the possibility
of the attenuated virus reverting to pathogenic, Perelberg et al.
(2005) irradiated it and selected additional clones appropriate
for vaccination. The results of their study suggest that a safe and
efﬁcient prophylactic vaccine can be developed by selecting an
appropriate attenuated virus. However, Yuasa and Sano (2009)
found that even though the attenuated vaccine is effective in
preventing the disease, the risk of reversion to its pathogenic form
is a potential threat.
Glycoprotein has been widely used for vaccine development
againstmany viruses such as viral hemorrhagic septicemia (Lecocq-
Xhonneux et al. 1994), hepatitis C virus (Stamataki et al. 2007),
avian inﬂuenza virus (Yang et al. 2010). Herpesviruses employ the
glycoproteins to enter cells, a process that involves fusion of the
virion envelope with cellular membranes (Farnsworth et al. 2007).
This KHV glycoprotein, ORF25 has been used for DNA vaccination
against KHV and showed the protection (Nuryati et al. 2010;
Nuswantoro et al. 2012; Zhou et al. 2014).
Beside the DNA vaccine, the recombinant proteins have been
used widely in development of ﬁsh vaccine. Recombinant capsid
protein of betanodavirus of nervous necrosis virus (Sommerset
et al. 2005; Lin et al. 2007), coat protein of nervous necrosis virus
(Kim et al. 2015), major coat protein of rock bream iridovirus (Shin
et al. 2013), protein ORF093 of infectious spleen and kidney ne-
crosis virus (ISKNV) (Li et al. 2015a), glycoprotein viral hemorrhagic
septicemia (Lecocq-Xhonneux et al. 1994) has been developed as
vaccines. The efﬁcacy of vaccination methods should be tested;
Sommerset et al. (2005) found that vaccination using recombinant
capsid protein of nodavirus produced higher protection compared
to recombinant DNA in turbot (Scophthalmus maximus). Similar
pattern was recorded by Fu et al. (2015) using ORF086 of ISKNV on
Murwantoko, et al148Chinese perch (Siniperca chuatsi). In this study we expressed KHV
ORF25 protein in E. coli.
The full length of KHV ORF25 from TUMSTI KHV strain
composed by 1806 nt and encoded 601 amino acids. In this study
the PCR amplicon length and sequencing result showed the DNA
fragment length of only 1012 bp. The primer was designed to
exclude the hydrophobic cluster area in order to achieve high
protein production. As in high level expression, hydrophobic
stretches in the polypeptide are present at high concentrations and
available for interaction with similar regions. All these factors lead
to protein instability and aggregation (Rosano and Ceccarelli 2014).
In this study theKHVORF25proteinwas successfully produced in
E. coli BL21 under pET32a (þ) system. The protein was expressed
dominantly and it was insoluble. Use of T7 promoter system in that
applied to the host will direct the host bacteria to produce target
protein up to 50% from the total protein produced (Sambrook and
Russel 2001). The protein expression of this study is better than
the similarprevious studybyMurwantokoet al. (2012)whichdidnot
show the dominant protein expressed band. The KHVORF25 protein
sizewas approximately 45 kDa. That size comes from approximately
337 amino acid residues from KHV ORF25 of this study and 162
amino acid residues from plasmid pET32 at upstream of KHV ORF25
such as Trx-Tag, His-Tag and S-Tag proteins and 18 amino acid resi-
dues at downstream of KHV ORF25 up to stop codon of pET32a.
T-cell epitope prediction analysis of this KHV ORF25 protein
showed that nine and eight epitopes were available based on
IAd and Rothbard/Taylor patterns, respectively. B-cell
epitope prediction showed this protein contains 3, 23, and 8 epi-
topes based on Emini surface accessibility, Karplus and Schulz
ﬂexibility and ElliPro scales, respectively. Many T-cell and B-cell
epitopes were recognized by more than one pattern. Those results
indicate that although this is partial protein of KHV ORF25, it is still
predicted to have high immunogenicity.
Glycosylation is one of the most common posttranslational
modiﬁcations of proteins. It has important roles for protein struc-
ture, stability and functions. In vivo the glycostructures inﬂuence
pharmacokinetics and immunogenicity. It is well known that sig-
niﬁcant differences in glycosylation and glycostructures exist be-
tween recombinant proteins expressed in mammalian, yeast and
insect cells. Different glycosylation in HEK and CHO mammalian
cells has been observed by Croset et al. (2012). Glycoproteins are
glycosylated with a bewilderingly heterogeneous array of complex
N- and O-linked glycans, which are the product of the coordinated
activity of enzymes resident in the endoplasmic reticulum and
Golgi apparatus of the cell (Brooks 2004). Since in this study protein
expression was on bacteria which do not have endoplasmic retic-
ulum and Golgi apparatus, the glycosylation of the protein was
expected to be very limited. To prove whether the lack of glyco-
sylation affect immunogenicity, the in vivo immunogenicity and
protection tests should be addressed.
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